[Mechanism of action of antitubercular drugs]. 1974

J Kuthy-Porter

UI MeSH Term Description Entries
D009169 Mycobacterium tuberculosis A species of gram-positive, aerobic bacteria that produces TUBERCULOSIS in humans, other primates, CATTLE; DOGS; and some other animals which have contact with humans. Growth tends to be in serpentine, cordlike masses in which the bacilli show a parallel orientation. Mycobacterium tuberculosis H37Rv
D000995 Antitubercular Agents Drugs used in the treatment of tuberculosis. They are divided into two main classes: "first-line" agents, those with the greatest efficacy and acceptable degrees of toxicity used successfully in the great majority of cases; and "second-line" drugs used in drug-resistant cases or those in which some other patient-related condition has compromised the effectiveness of primary therapy. Anti-Tuberculosis Agent,Anti-Tuberculosis Agents,Anti-Tuberculosis Drug,Anti-Tuberculosis Drugs,Antitubercular Agent,Antitubercular Drug,Tuberculostatic Agent,Tuberculostatic Agents,Antitubercular Drugs,Agent, Anti-Tuberculosis,Agent, Antitubercular,Agent, Tuberculostatic,Anti Tuberculosis Agent,Anti Tuberculosis Agents,Anti Tuberculosis Drug,Anti Tuberculosis Drugs,Drug, Anti-Tuberculosis,Drug, Antitubercular

Related Publications

J Kuthy-Porter
December 1975, Kekkaku : [Tuberculosis],
J Kuthy-Porter
January 1966, Giornale italiano di chemioterapia,
J Kuthy-Porter
March 1977, Kekkaku : [Tuberculosis],
J Kuthy-Porter
January 1967, Tuberkuloza,
J Kuthy-Porter
October 1964, La Clinica pediatrica,
J Kuthy-Porter
January 1970, Problemy tuberkuleza,
J Kuthy-Porter
January 1968, Zeitschrift fur Tuberkulose und Erkrankungen der Thoraxorgane,
J Kuthy-Porter
December 1960, France Medecine,
J Kuthy-Porter
January 1966, Il Friuli medico,
J Kuthy-Porter
January 1998, Pneumoftiziologia : revista Societatii Romane de Pneumoftiziologie,
Copied contents to your clipboard!